Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Mattsson

Showing results (111-120 of 258) with videos related to

Pageof 26
Sort By:
Stem Cells (Dayton, Ohio)|January 12, 2013
Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host diseaseOlle Ringdén, Tom Erkers, Silvia Nava, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004
Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemiaAnna Nordlander, Jonas Mattsson, Olle Ringdén, et al.
Stem Cells and Development|August 25, 2011
Mesenchymal stem cells inhibit thymic reconstitution after allogeneic cord blood transplantationMichael Uhlin, Darius Sairafi, Sofia Berglund, et al.
Expert Review of Hematology|September 1, 2020
Patient-reported symptom burden of chronic graft versus host disease: a systematic literature reviewMarcell Csanádi, Tamas Ágh, Szabolcs Farkas-Ráduly, et al.
European Journal of Haematology|September 15, 2012
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disordersOlle Ringdén, Mats Remberger, Göran Dahllöf, et al.
The Prostate|August 12, 2014
Novel method to characterize immune cells from human prostate tissueMelissa M Norström, Emelie Rådestad, Arwen Stikvoort, et al.
Transplantation|April 15, 2008
Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutritionBritt-Marie Svahn, Mats Remberger, Mona Heijbel, et al.
American Journal of Obstetrics and Gynecology|August 24, 2002
Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiencyMagnus Westgren, Olle Ringdén, Peter Bartmann, et al.
Journal for Immunotherapy of Cancer|June 23, 2022
Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stressStefanie Renken, Takahiro Nakajima, Isabelle Magalhaes, et al.
Antimicrobial Agents and Chemotherapy|June 4, 2014
Posaconazole concentrations in human tissues after allogeneic stem cell transplantationOla Blennow, Erik Eliasson, Tommy Pettersson, et al.
Pageof 26

Showing results (111-120 of 258) with videos related to

Sort By:
Pageof 26
Stem Cells (Dayton, Ohio)|January 12, 2013
Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host diseaseOlle Ringdén, Tom Erkers, Silvia Nava, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004
Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemiaAnna Nordlander, Jonas Mattsson, Olle Ringdén, et al.
Stem Cells and Development|August 25, 2011
Mesenchymal stem cells inhibit thymic reconstitution after allogeneic cord blood transplantationMichael Uhlin, Darius Sairafi, Sofia Berglund, et al.
Expert Review of Hematology|September 1, 2020
Patient-reported symptom burden of chronic graft versus host disease: a systematic literature reviewMarcell Csanádi, Tamas Ágh, Szabolcs Farkas-Ráduly, et al.
European Journal of Haematology|September 15, 2012
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disordersOlle Ringdén, Mats Remberger, Göran Dahllöf, et al.
The Prostate|August 12, 2014
Novel method to characterize immune cells from human prostate tissueMelissa M Norström, Emelie Rådestad, Arwen Stikvoort, et al.
Transplantation|April 15, 2008
Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutritionBritt-Marie Svahn, Mats Remberger, Mona Heijbel, et al.
American Journal of Obstetrics and Gynecology|August 24, 2002
Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiencyMagnus Westgren, Olle Ringdén, Peter Bartmann, et al.
Journal for Immunotherapy of Cancer|June 23, 2022
Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stressStefanie Renken, Takahiro Nakajima, Isabelle Magalhaes, et al.
Antimicrobial Agents and Chemotherapy|June 4, 2014
Posaconazole concentrations in human tissues after allogeneic stem cell transplantationOla Blennow, Erik Eliasson, Tommy Pettersson, et al.
Pageof 26